gastric cancer
Conditions
Interventions
experimental group :Laparoscopy-assisted radical gastrectomy with omentum-preserving
control group:Laparoscopy-assisted radical gastrectomy with complete omentectomy
Sponsors
The Third Affiliated Hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 20 to 70 years, informed consent; 2. The primary lesion of the gastric cavity was diagnosed as gastric cancer by endoscopic biopsy (tubular adenocarcinoma tub, papillary adenocarcin pap, mucinous adenocarcinoma muc, signet ring cell carcinoma sig); 3. For preoperative staging, it can be T2-4N0-2M0 (see preoperative evaluation protocol; according to AJCC-7th TNM tumor staging); 4. It is expected that radical gastrectomy + D2 lymph node dissection will result in R0 surgery (multiple primary cancer is also applicable); 5. Preoperative ECOG physical status score 0 / 1; 6. Preoperative ASA scores I-III.
Exclusion criteria
Exclusion criteria: 1. Patients with acute obstruction, perforation or hemorrhage; 2. The tumor is huge or has extensively invaded surrounding tissues and organs and cannot be cured; 3. Preoperative imaging examination revealed a fusion of enlarged lymph nodes (maximum diameter >= 3 cm); 4. Due to the combined factors of local anatomy and tumor site, it is necessary to perform gastrostomy; 5. Concomitant with other malignant diseases or other malignant diseases within 5 years; 6. Consolidation of other diseases requires concurrent surgery; 7. Have a history of large surgery in the abdomen; 8. Suffering from a serious mental illness; 9. Heart, brain, lung and other important organs are insufficiency and cannot tolerate the operator; 10. Have a history of unstable angina or myocardial infarction within 6 months, or have a history of cerebral infarction or cerebral hemorrhage; 11. There is a history of continuous systemic corticosteroids or immunosuppressive drugs in January.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 year overall survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| conversion rate;mortality rates;complication rate;1 year recurrence rate;1 year disease free survival rate;Postoperative recovery course; | — |
Countries
China
Contacts
Public ContactJianglong Huang
Department of Gastrointestinal Surgery, the Third Affiliated Hospital of Sun Yat-Sen University
Outcome results
None listed